FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2099144295> ?p ?o ?g. }

• W2099144295 endingPage "32" @default.
• W2099144295 startingPage "32" @default.
• W2099144295 abstract "We have recently reported that the dietary supplement Meltdown® increases plasma norepinephrine (NE), epinephrine (EPI), glycerol, free fatty acids (FFA), and metabolic rate in men. However, in that investigation measurements ceased at 90 minutes post ingestion, with values for blood borne variables peaking at this time. It was the purpose of the present investigation to extend the time course of measurement to 6 hours, and to include women within the design to determine if sex differences to treatment exist. Ten men (24 ± 4 yrs) and 10 women (22 ± 2 yrs) ingested Meltdown® or a placebo, using a randomized, cross-over design with one week separating conditions. Blood samples were collected immediately before supplementation and at one hour intervals through 6 hours post ingestion. A standard meal was provided after the hour 3 collection. Samples were assayed for EPI, NE, glycerol, and FFA. Five minute breath samples were collected at each time for measurement of metabolic rate and substrate utilization. Area under the curve (AUC) was calculated. Heart rate and blood pressure were recorded at all times. Data were also analyzed using a 2 (sex) × 2 (condition) × 7 (time) repeated measures analysis of variance, with Tukey post hoc testing. No sex × condition interactions were noted for AUC for any variable (p > 0.05). Hence, AUC data are collapsed across men and women. AUC was greater for Meltdown® compared to placebo for EPI (367 ± 58 pg·mL-1·6 hr-1 vs. 183 ± 27 pg·mL-1·6 hr-1; p = 0.01), NE (2345 ± 205 pg·mL-1·6 hr-1 vs. 1659 ± 184 pg·mL-1·6 hr-1; p = 0.02), glycerol (79 ± 8 μg·mL-1·6 hr-1 vs. 59 ± 6 μg·mL-1·6 hr-1; p = 0.03), FFA (2.46 ± 0.64 mmol·L-1·6 hr-1 vs. 1.57 ± 0.42 mmol·L-1·6 hr-1; p = 0.05), and kilocalorie expenditure (439 ± 26 kcal·6 hrs-1 vs. 380 ± 14 kcal·6 hrs-1; p = 0.02). No effect was noted for substrate utilization (p = 0.39). Both systolic and diastolic blood pressure (p < 0.0001; 1–16 mmHg), as well as heart rate (p = 0.01; 1–9 bpm) were higher for Meltdown®. No sex × condition × time interactions were noted for any variable (p > 0.05). Ingestion of Meltdown® results in an increase in catecholamine secretion, lipolysis, and metabolic rate in young men and women, with a similar response for both sexes. Meltdown® may prove to be an effective intervention strategy for fat loss, assuming individuals are normotensive and their treatment is monitored by a qualified health care professional." @default.
• W2099144295 created "2016-06-24" @default.
• W2099144295 creator A5042714701 @default.
• W2099144295 creator A5047779719 @default.
• W2099144295 creator A5052821878 @default.
• W2099144295 creator A5062509091 @default.
• W2099144295 creator A5070379902 @default.
• W2099144295 creator A5085376018 @default.
• W2099144295 date "2009-01-01" @default.
• W2099144295 modified "2023-10-16" @default.
• W2099144295 title "Effect of the dietary supplement Meltdown on catecholamine secretion, markers of lipolysis, and metabolic rate in men and women: a randomized, placebo controlled, cross-over study" @default.
• W2099144295 cites W103751348 @default.
• W2099144295 cites W1483105549 @default.
• W2099144295 cites W1880643080 @default.
• W2099144295 cites W1977657113 @default.
• W2099144295 cites W1979359527 @default.
• W2099144295 cites W1981043298 @default.
• W2099144295 cites W1988643311 @default.
• W2099144295 cites W2006179567 @default.
• W2099144295 cites W2023795430 @default.
• W2099144295 cites W2027492954 @default.
• W2099144295 cites W2031600325 @default.
• W2099144295 cites W2035357746 @default.
• W2099144295 cites W2053283461 @default.
• W2099144295 cites W2064274934 @default.
• W2099144295 cites W2069992798 @default.
• W2099144295 cites W2076847624 @default.
• W2099144295 cites W2091530001 @default.
• W2099144295 cites W2093625062 @default.
• W2099144295 cites W2095780917 @default.
• W2099144295 cites W2097060123 @default.
• W2099144295 cites W2112932880 @default.
• W2099144295 cites W2135532152 @default.
• W2099144295 cites W2137167940 @default.
• W2099144295 cites W2138215600 @default.
• W2099144295 cites W2141238396 @default.
• W2099144295 cites W2145793841 @default.
• W2099144295 cites W2156579478 @default.
• W2099144295 cites W2157756843 @default.
• W2099144295 cites W2161204617 @default.
• W2099144295 doi "https://doi.org/10.1186/1476-511x-8-32" @default.
• W2099144295 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2728713" @default.
• W2099144295 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19656409" @default.
• W2099144295 hasPublicationYear "2009" @default.
• W2099144295 type Work @default.
• W2099144295 sameAs 2099144295 @default.
• W2099144295 citedByCount "27" @default.
• W2099144295 countsByYear W20991442952012 @default.
• W2099144295 countsByYear W20991442952013 @default.
• W2099144295 countsByYear W20991442952014 @default.
• W2099144295 countsByYear W20991442952015 @default.
• W2099144295 countsByYear W20991442952016 @default.
• W2099144295 countsByYear W20991442952017 @default.
• W2099144295 countsByYear W20991442952018 @default.
• W2099144295 countsByYear W20991442952020 @default.
• W2099144295 countsByYear W20991442952021 @default.
• W2099144295 countsByYear W20991442952023 @default.
• W2099144295 crossrefType "journal-article" @default.
• W2099144295 hasAuthorship W2099144295A5042714701 @default.
• W2099144295 hasAuthorship W2099144295A5047779719 @default.
• W2099144295 hasAuthorship W2099144295A5052821878 @default.
• W2099144295 hasAuthorship W2099144295A5062509091 @default.
• W2099144295 hasAuthorship W2099144295A5070379902 @default.
• W2099144295 hasAuthorship W2099144295A5085376018 @default.
• W2099144295 hasBestOaLocation W20991442951 @default.
• W2099144295 hasConcept C126322002 @default.
• W2099144295 hasConcept C134018914 @default.
• W2099144295 hasConcept C140793950 @default.
• W2099144295 hasConcept C140985366 @default.
• W2099144295 hasConcept C142724271 @default.
• W2099144295 hasConcept C148257392 @default.
• W2099144295 hasConcept C171089720 @default.
• W2099144295 hasConcept C193230392 @default.
• W2099144295 hasConcept C204787440 @default.
• W2099144295 hasConcept C27081682 @default.
• W2099144295 hasConcept C2777953023 @default.
• W2099144295 hasConcept C2778345441 @default.
• W2099144295 hasConcept C71924100 @default.
• W2099144295 hasConcept C76318530 @default.
• W2099144295 hasConcept C84393581 @default.
• W2099144295 hasConcept C86803240 @default.
• W2099144295 hasConcept C99476002 @default.
• W2099144295 hasConceptScore W2099144295C126322002 @default.
• W2099144295 hasConceptScore W2099144295C134018914 @default.
• W2099144295 hasConceptScore W2099144295C140793950 @default.
• W2099144295 hasConceptScore W2099144295C140985366 @default.
• W2099144295 hasConceptScore W2099144295C142724271 @default.
• W2099144295 hasConceptScore W2099144295C148257392 @default.
• W2099144295 hasConceptScore W2099144295C171089720 @default.
• W2099144295 hasConceptScore W2099144295C193230392 @default.
• W2099144295 hasConceptScore W2099144295C204787440 @default.
• W2099144295 hasConceptScore W2099144295C27081682 @default.
• W2099144295 hasConceptScore W2099144295C2777953023 @default.
• W2099144295 hasConceptScore W2099144295C2778345441 @default.
• W2099144295 hasConceptScore W2099144295C71924100 @default.
• W2099144295 hasConceptScore W2099144295C76318530 @default.
• W2099144295 hasConceptScore W2099144295C84393581 @default.
• W2099144295 hasConceptScore W2099144295C86803240 @default.

• next